LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - 89bio (NASDAQ: ETNB)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ETNB 89bio
Mansbach Harry H / officer: Chief Medical Officer
09/09/2024
Sell
$8.46
5,352
$45K
152,039
NASDAQ ETNB 89bio
Martins Ryan / officer: Chief Financial Officer
09/09/2024
Sell
$8.46
3,212
$27K
102,620
NASDAQ ETNB 89bio
Le-Nguyen Quoc / officer: See Remarks
09/09/2024
Sell
$8.46
5,352
$45K
215,751
NASDAQ ETNB 89bio
Mansbach Harry H / officer: Chief Medical Officer
08/17/2024
Sell
$8.04
1,046
$8K
157,391
NASDAQ ETNB 89bio
PALEKAR ROHAN / director, officer: Chief Executive Officer
08/17/2024
Sell
$8.04
4,601
$37K
456,236
NASDAQ ETNB 89bio
Martins Ryan / officer: Chief Financial Officer
08/17/2024
Sell
$8.04
777
$6K
105,832
NASDAQ ETNB 89bio
Le-Nguyen Quoc / officer: See Remarks
08/17/2024
Sell
$8.04
1,046
$8K
221,103
NASDAQ ETNB 89bio
McWherter Charles / director
08/05/2024
Buy
$8.39
67,700
$568K
67,700
NASDAQ ETNB 89bio
Sarena Francis Willard / officer: Chief Operating Officer
08/05/2024
Buy
$8.39
350,000
$2.937M
350,000

COPYRIGHT ©2023 HEALTH STOCKS HUB